Clinical Report: Uncoupling of Right Ventricular and Pulmonary Arterial Function

Background

Acute pulmonary embolism is a leading cause of cardiovascular mortality, with a significant proportion of patients presenting as normotensive. Despite normal blood pressure, these patients are at high risk for clinical deterioration and mortality. Understanding the hemodynamic implications of right ventricular dysfunction is crucial for timely intervention. This is supported by findings from Kucher et al. (2026) which indicate that qualitative RV hypokinesis independently predicts 30-day mortality in normotensive PE patients.

Data Highlights

No numerical data available in the source material due to the nature of the studies referenced.

Key Findings

• Qualitative RV hypokinesis predicts 30-day mortality in normotensive PE patients (Adjusted HR: 1.94; Kucher et al., 2026).
• A reduced TAPSE/PASP ratio is independently associated with 30-day mortality across PE severity (Lyhne et al., 2026).
• Incorporating TAPSE/PASP into risk assessment improves classification compared to ESC guidelines (Brusca and Holtzman, 2026).
• A TAPSE/PASP ratio below 0.34 mm/mmHg reliably detects RV-PA uncoupling with high sensitivity and specificity (Yuriditsky et al., 2026).
• TRV measurement is often inadequate, limiting the use of TAPSE/PASP for assessment (Bowcock et al., 2026).

Clinical Implications

The findings indicate the importance of comprehensive RV assessment in normotensive PE patients to identify those at risk for deterioration, as supported by the studies referenced.

Conclusion

The uncoupling of right ventricular and pulmonary arterial function in normotensive shock presents significant clinical challenges. Further research is needed to explore effective management strategies for acute pulmonary embolism.

Related Resources & Content

1. Hunsicker et al., JACC, 2026 -- Uncoupling of Right Ventricular and Pulmonary Arterial Function
2. Kucher et al., JACC, 2026 -- Right Ventricular Dysfunction in Pulmonary Embolism
3. Brusca and Holtzman, JACC, 2026 -- Risk Assessment in Acute PE
4. Bowcock et al., NEDA, 2026 -- TRV Measurement in Critically Ill Patients
5. Yuriditsky et al., JACC, 2026 -- Prognostic Value of TAPSE/PASP Ratio
6. Critical Care (Springer) — Ventricular septum curvature ratio: a novel imaging marker to predict clinical deterioration in normotensive acute pulmonary embolism
7. Frontiers in Cardiovascular Medicine — Utilization of ECMO and Percutaneous Mechanical Thrombectomy in Treating Acute Pulmonary Embolism
8. Clinical Research in Cardiology — Impact of Combined VAV-ECMO, Impella CP, and Impella RP on Hemodynamics
9. Clinical Research in Cardiology — Managing Ventilation in Veno-Arterial Extracorporeal Membrane Oxygenation
10. 2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/SVN Guideline for the Evaluation and Management of Acute Pulmonary Embolism in Adults
11. Utilization of ECMO and Percutaneous Mechanical Thrombectomy in Treating Acute Pulmonary Embolism
12. Impact of Combined VAV-ECMO, Impella CP, and Impella RP on Hemodynamics
13. Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism | New England Journal of Medicine